CJC-1295 & GHRP-2 Blend (10mg) Research Peptide: A Dual‑Pathway Synergistic Tool for Growth Hormone Studies

If your research explores the hypothalamic-pituitary-somatotropic axis, the dynamics of growth hormone (GH) secretion, or the downstream metabolic effects of GH and IGF-1, the CJC-1295 & GHRP-2 Blend (10mg) research peptide offers a precisely defined, dual‑pathway experimental platform. This 10 mg formulation combines two mechanistically distinct yet complementary GH secretagogues—CJC-1295 (Mod GRF 1-29), a modified, long‑acting analogue of growth hormone‑releasing hormone (GHRH), and GHRP-2 (Pralmorelin), a potent ghrelin receptor agonist. By simultaneously targeting the GHRH receptor and the growth hormone secretagogue receptor (GHS‑R1a), this blend allows researchers to model the synergistic interplay between sustained baseline stimulation and pulsatile bursts, providing deeper insight into the regulatory circuits that govern GH pulsatility and IGF‑1 signalling.

At Chinese Grey Peptides, we supply high‑purity CJC-1295 & GHRP-2 Blend (10mg) research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥99% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into GH regulation, IGF‑1 signalling, and metabolic research begin with uncompromising quality.

What Is the CJC‑1295 & GHRP‑2 Blend and How Does It Work?

To fully appreciate the research potential of the CJC-1295 & GHRP-2 Blend (10mg) research peptide, it is essential to understand the distinct yet complementary mechanisms of its two components. Each peptide exploits a separate G‑protein‑coupled receptor (GPCR) with divergent downstream signalling, yet both ultimately converge on the somatotroph’s secretory machinery.

CJC-1295 (Mod GRF 1-29): The Long‑Acting GHRH Analog

CJC‑1295 is a synthetic peptide derivative of growth hormone‑releasing hormone (GHRH), specifically a tetrasubstituted analogue of the N‑terminal 29 amino acids of hGRF(1‑29). Unlike CJC‑1295‑DAC, which contains a drug affinity complex (DAC) moiety and has an extended half‑life of approximately 6‑8 days, the version in this blend—CJC‑1295 without DAC (also called Modified GRF 1‑29)—does not contain the DAC moiety. However, it still features four specific amino acid substitutions—at positions 2, 8, 15, and 27—that confer resistance to enzymatic degradation and enhance bioactivity.

The absence of the DAC moiety is a deliberate design feature: CJC‑1295 without DAC has a half‑life of approximately 30 minutes and supports a more physiological pulsatile release pattern that closely mimics the body’s natural GH rhythm. The version without DAC creates GH pulses that mimic natural physiology, supporting a more pulsatile release pattern that closely resembles endogenous GHRH signalling.

GHRP-2 (Pralmorelin): The Potent Ghrelin Receptor Agonist

GHRP‑2 (Growth Hormone Releasing Peptide‑2, also known as Pralmorelin or KP‑102) is a synthetic hexapeptide belonging to the growth hormone secretagogue (GHS) class. It acts as a ghrelin mimetic, binding to the ghrelin receptor (GHS‑R1a), a GPCR expressed in the hypothalamus and pituitary.

GHRP‑2 triggers GH release through several pathways, including calcium channel modulation, cAMP pathway activation, and protein kinase C signalling. A characteristic feature is that its effect is synergistic with GHRH, producing GH release that exceeds the additive sum of either peptide alone.

Mechanism of Synergy: Sustained Stimulation Meets Pulsatile Amplification

The scientific rationale for combining CJC‑1295 and GHRP‑2 lies in their convergent yet distinct mechanisms. When conceptualised as a blended research framework, these peptides invite investigation into how their complementary properties might interact:

• CJC‑1295 provides sustained baseline GHRH‑receptor engagement via the cAMP/PKA signalling cascade, supporting prolonged stimulation of GH synthesis and a steady elevation of IGF‑1 production.

• GHRP‑2 induces robust, rhythmic GH pulses through ghrelin receptor activation, creating dynamic peaks of GH secretion.

GHRH + GHRP combinations produce GH release greater than the sum of either agent alone, with studies demonstrating that combining GHRP-2 with GHRH analogs produces synergistic GH output that exceeds either agent alone by two to three times. The theorised synergy arises from sustained baseline GH stimulation via CJC‑1295, combined with pulsatile bursts from GHRP‑2, potentially creating a more dynamic and prolonged GH‑IGF‑1 milieu than either peptide alone.

CJC-1295 opens the GHRH pathway while GHRP-2 stimulates the ghrelin receptor, and hitting both at once produces a larger, more natural GH pulse than either alone. The combination may allow researchers to study long‑term endocrine regulation, tissue remodelling, and metabolism in more dynamic and controlled models.

Key Research Applications for the CJC-1295 & GHRP-2 Blend (10mg)

The CJC-1295 & GHRP-2 Blend (10mg) research peptide is a versatile tool with applications spanning several domains of endocrinological and metabolic research.

1. Growth Hormone Axis & Pituitary Function Studies

This blend provides a powerful model for investigating the hypothalamic‑pituitary‑somatotropic axis. Researchers can use it to study:

• The synergistic effects of GHRH and ghrelin pathway co‑activation on GH synthesis, storage, and pulsatile release

• The distinct contributions of GHRH‑mediated and ghrelin‑mediated signalling to overall GH secretion

• The dynamics of GH pulse amplitude and frequency in response to dual‑pathway stimulation

• The potential for sustained baseline receptor activity layered with pulsatile peaks to yield unique hormonal output patterns

2. Metabolic & Body Composition Research

By stimulating endogenous GH release through two pathways, this blend provides a model for studying the downstream metabolic effects of GH and IGF‑1 elevation. Research applications include:

• Lipid Metabolism: Exploring the role of GH in lipolysis and fat oxidation pathways

• Glucose Homeostasis: Investigating how GH modulation impacts glucose regulation and insulin sensitivity

• Body Composition: Studying how enhanced GH secretion may influence lean tissue accrual and reduce adipose deposition

• Metabolic Disorders: Exploring the blend’s potential to inform research on obesity and insulin resistance

3. Tissue Repair & Anabolic Signalling Research

GH and IGF‑1 are central to anabolic signalling cascades, involving pathways like JAK‑STAT and others implicated in protein synthesis and cellular growth. Research applications include:

• Muscle Cell Regeneration: Investigating the blend’s potential to support muscle tissue hypertrophy and suppress muscle‑degrading enzymes like atrogin‑1 and MuRF1

• Connective Tissue Remodelling: Exploring the effects of amplified GH‑IGF‑1 signalling on collagen and extracellular matrix dynamics

• Bone and Skeletal Research: Investigating potential impacts on bone mineral content and skeletal development, with relevance to osteoporosis and bone growth dynamics

4. Neuroprotective & Neuromodulatory Research

GH and related secretagogues are believed to engage neuroendocrine networks, potentially influencing neurogenesis, cognitive function, and neuronal resilience. Research applications include:

• Neuroprotection: Investigating GH‑mediated neuroprotective properties in degenerative research models

• Neuromodulation: Exploring synaptic plasticity and neuroregenerative pathways

• Cognitive Function: Studying the potential impact of GH modulation on cognitive function and neuronal resilience

5. Immunomodulatory Research

GHRP‑2 has demonstrated immunomodulatory properties in research models. Research applications include:

• Immune Regulation: Investigating how ghrelin receptor activation influences immune cell function and inflammatory signalling

• Cytokine Modulation: Exploring the broader effects of GH‑axis modulation on immune homeostasis

Chemical & Physical Specifications for CJC-1295 & GHRP-2 Blend (10mg)

Accurate characterisation of the CJC-1295 & GHRP-2 Blend (10mg) research peptide is essential for reproducible experimental design.

Note: The 10 mg mass represents the total peptide weight of the blend. The exact ratio of CJC‑1295 (Mod GRF 1‑29) to GHRP‑2 is determined by the formulation (contact for details). The blend is supplied in a single lyophilised vial. CJC‑1295 in this blend does not contain the Drug Affinity Complex (DAC) moiety.

Reconstitution & Handling Protocol for the CJC-1295 & GHRP-2 Blend (10mg)

Proper reconstitution of the CJC-1295 & GHRP-2 Blend (10mg) research peptide is critical for maintaining the structural integrity and biological activity of both peptides.

Step 1 – Preparation

• Bring the sealed blend vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature.

• Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.

Step 2 – Vial Sanitisation

• Wipe the rubber stopper of the blend vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.

Step 3 – Reconstitution

• Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 10 mg per 1 mL of diluent, yielding a 10 mg/mL total peptide concentration.

• Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.

• Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously.

Step 4 – Aliquoting & Storage

• Immediately after dissolution, aliquot the reconstituted peptide blend into single‑use sterile vials.

• Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles.

• Once thawed, store at 2‑8°C and use within a short period.

Concentration Reference Table for CJC-1295 & GHRP-2 Blend (10mg)

Adjust diluent volume based on your experimental requirements. The exact concentration of each individual peptide within the blend is determined by the formulation’s component ratio.

Storage & Stability Guidelines for CJC-1295 & GHRP-2 Blend (10mg)

Why Choose Chinese Grey Peptides for the CJC-1295 & GHRP-2 Blend (10mg)?

As an authentic licensed peptide supplier based in the USA, we supply the CJC-1295 & GHRP-2 Blend (10mg) research peptide and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).

• Verified Purity: Independent HPLC analysis with purity guaranteed ≥99% for each component, every batch.

• GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.

• Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.

• Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.

• USA‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO).

Researchers across the United States—including those at leading institutions—trust us for fast domestic delivery, transparent documentation and professional technical support.

FAQ: CJC‑1295 & GHRP‑2 Blend (10mg) Research Peptide

What is the CJC-1295 & GHRP-2 Blend (10mg) research peptide?
It is a research‑grade formulation combining CJC‑1295 (Mod GRF 1‑29, a modified GHRH analogue) and GHRP‑2 (a potent ghrelin receptor agonist). It is used as a dual‑pathway tool to study growth hormone stimulation, IGF‑1 signalling, and metabolic research.

 How does each component work?
CJC‑1295 (Mod GRF 1‑29) binds to GHRH receptors on pituitary somatotrophs, stimulating GH synthesis and release via the cAMP/PKA pathway. GHRP‑2 binds to the growth hormone secretagogue receptor (GHS‑R1a), stimulating GH release through calcium channel modulation, cAMP pathway activation, and protein kinase C signalling.

What is the proposed synergy between CJC‑1295 and GHRP‑2?
CJC‑1295 provides sustained baseline GH stimulation, while GHRP‑2 induces pulsatile bursts of GH release. This dual‑phase stimulation may lead to a more consistent and prolonged modulation of the GH/IGF‑1 axis than either peptide alone. GHRH + GHRP combinations produce GH release greater than the sum of either agent alone.

What is the difference between CJC‑1295 with DAC and without DAC?
CJC‑1295 without DAC (Mod GRF 1‑29) does not contain a drug affinity complex moiety and has a half‑life of approximately 30 minutes. The version without DAC supports a more pulsatile release pattern that more closely mimics natural physiology.

What purity does your CJC-1295 & GHRP-2 Blend (10mg) meet?
Each component is tested to ≥99% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.

How should I reconstitute this peptide blend?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake.

How should I store reconstituted peptide blends?
Reconstituted blends should be stored at 2‑8°C for short‑term use. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.

Is this peptide blend legal to purchase in the USA for research?
Yes. This blend is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United States for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims. Note: CJC‑1295 and GHRP‑2 are not FDA‑approved for human use and are prohibited by the World Anti‑Doping Agency (WADA) for athletic use.

Does Chinese Grey Peptides ship internationally?
Yes. We ship across the UK, Europe (France, Germany, Spain, Sweden, Italy), and the USA from our US warehouse. Wholesale pricing is available for bulk orders.

CJC-1295 & GHRP-2 Blend (10mg)

1. Shop Page
2. Bulk Orders Page
3. Contact Page
4. Shipping & Return Page
5. Peptide Purity Page

• PubChem CJC-1295
• PubChem Pralmorelin / GHRP-2
• FDA compounding-risk page for CJC-1295
• WADA growth-hormone-releasing-factor context
• Google Merchant Center structured data guidance
• Rank Math WooCommerce Product Schema

CJC-1295 & GHRP-2 Blend (10mg)

Ships to USA, Canada, UK & Europe

Chinese Grey Peptides supports shipping to the USA, Canada, the United Kingdom, France, Germany, Spain, Sweden, Italy, and Europe where permitted.

Shipping support may include:

• Order processing updates
• Packaging support
• Tracking information where available
• Wholesale shipment planning
• Destination-based shipping review
• Customer support during transit

Shipping times may vary by order size, carrier, destination, customs process, product status, and local requirements.

Why Choose Chinese Grey Peptides?

Chinese Grey Peptides focuses on quality, support, and clear communication. We help buyers review product details before placing an order.

Customers choose us for:

• Professional peptide supplier support
• Small and wholesale order options
• Product documentation support
• HPLC testing information where available
• Mass Spectrum documentation where available
• International shipping support
• Responsive communication
• Clear order assistance before payment

We aim to make the buying process transparent, professional, and documentation-focused.

CJC-1295 & GHRP-2 Blend (10mg)

Important Compliance Notice

CJC-1295 GHRP-2 Blend 10mg may be regulated differently depending on the country, product type, labeling, intended use, buyer type, and destination. Chinese Grey Peptides does not provide medical advice, dosing instructions, injection guidance, growth hormone claims, anti-aging claims, fat-loss claims, muscle-growth claims, recovery claims, athletic-performance claims, bodybuilding claims, disease claims, treatment claims, or personal-use recommendations.

Customers are responsible for understanding and following all local laws, import rules, prescription requirements, compounding rules, sport-governing rules, labeling rules, and permitted-use requirements before ordering.

CJC-1295 & GHRP-2 Blend (10mg)

From its innovative design as a dual‑pathway GH secretagogue blend to its well‑documented role in modelling the synergistic interplay between the GHRH and ghrelin systems, the CJC-1295 & GHRP-2 Blend (10mg) research peptide provides a uniquely versatile platform for advanced endocrinological and metabolic research.

Its ability to stimulate endogenous GH release through two distinct yet convergent pathways—sustained baseline stimulation via CJC‑1295 and pulsatile amplification via GHRP‑2—supported by research demonstrating synergistic GH release exceeding the sum of individual effects, makes it a valuable addition to any laboratory investigating the GH/IGF‑1 axis. By choosing high‑purity, lab‑verified CJC-1295 & GHRP-2 Blend (10mg) research peptide from Chinese Grey Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.

Ready to advance your research with the CJC-1295 & GHRP-2 Blend (10mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade research peptides delivered directly to your facility in the USA, UK, or Europe.CJC-1295 & GHRP-2 Blend (10mg)